{"id":3700,"date":"2023-11-06T12:49:31","date_gmt":"2023-11-06T10:49:31","guid":{"rendered":"https:\/\/info.e-med.co.il\/remsima\/?p=3700"},"modified":"2024-05-06T12:52:59","modified_gmt":"2024-05-06T09:52:59","slug":"higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease","status":"publish","type":"post","link":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/","title":{"rendered":"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease"},"content":{"rendered":"<h3 class=\"title\" dir=\"ltr\" style=\"text-align: left;\">Abstract<\/h3>\n<div id=\"eng-abstract\" class=\"abstract-content selected\">\n<p dir=\"ltr\" style=\"text-align: left;\"><strong class=\"sub-title\">Background:\u00a0<\/strong>The relationship between SC-IFX concentrations and favorable therapeutic outcomes in patients with Crohn's disease (CD) and ulcerative colitis (UC) remain elusive.<\/p>\n<p style=\"text-align: right;\"><strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37934041\/\" target=\"_blank\" rel=\"noopener\">\u05dc\u05d4\u05de\u05e9\u05da \u05e7\u05e8\u05d9\u05d0\u05d4<\/a><\/strong><\/p>\n<\/div>\n<p dir=\"ltr\">Roblin X, Nancey S, Papamichael K, Duru G, Flamand M, Kwiatek S, Cheifetz A, Fabien N, Barrau M, Paul S. Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease. J Crohns Colitis. 2023 Nov 2:jjad188. doi: 10.1093\/ecco-jcc\/jjad188. Epub ahead of print. PMID: 37934041.<\/p>\n","protected":false},"excerpt":{"rendered":"<p dir=\"ltr\"><strong>Roblin X et.al.; J Crohns Colitis. 2023 Nov 2:jjad188<\/strong><\/p>\n","protected":false},"author":2,"featured_media":3555,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"footnotes":""},"categories":[28,26,24],"tags":[],"class_list":["post-3700","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-article-en","category-research","category-updates-news"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Roblin X et.al.; J Crohns Colitis. 2023 Nov 2:jjad188\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"&#039;\u05de\u05e2\u05e8\u05db\u05ea \u05d0\u05d9\u05de\u05d3&#039;\"\/>\n\t<meta name=\"keywords\" content=\"article,\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd,\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"he_IL\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Remsima | \u05e8\u05de\u05e1\u05d9\u05de\u05d4 120 \u05de&quot;\u05d2\/\u05de&quot;\u05dc \u05ea\u05ea -\u05e2\u05d5\u05e8\u05d9 \u05d4\u05d9\u05e0\u05d5 \u05d4\u05d0\u05d9\u05e0\u05e4\u05dc\u05d9\u05e7\u05e1\u05d9\u05de\u05d0\u05d1 \u05d4\u05d9\u05d7\u05d9\u05d3 \u05db\u05d9\u05d5\u05dd \u05d4\u05e0\u05d9\u05ea\u05df \u05d1\u05de\u05ea\u05df \u05ea\u05ea-\u05e2\u05d5\u05e8\u05d9\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease | Remsima\" \/>\n\t\t<meta property=\"og:description\" content=\"Roblin X et.al.; J Crohns Colitis. 2023 Nov 2:jjad188\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-11-06T10:49:31+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2024-05-06T09:52:59+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease | Remsima\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Roblin X et.al.; J Crohns Colitis. 2023 Nov 2:jjad188\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#article\",\"name\":\"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease | Remsima\",\"headline\":\"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease\",\"author\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/author\\\/naama2shomroni23\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/files\\\/2023\\\/10\\\/colitus.jpg\",\"width\":674,\"height\":506},\"datePublished\":\"2023-11-06T12:49:31+02:00\",\"dateModified\":\"2024-05-06T12:52:59+03:00\",\"inLanguage\":\"he-IL\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#webpage\"},\"articleSection\":\"Article, \\u05de\\u05d7\\u05e7\\u05e8\\u05d9\\u05dd \\u05d5\\u05e4\\u05e8\\u05e1\\u05d5\\u05de\\u05d9\\u05dd, \\u05e2\\u05d3\\u05db\\u05d5\\u05e0\\u05d9\\u05dd\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/updates-news\\\/#listItem\",\"name\":\"\\u05e2\\u05d3\\u05db\\u05d5\\u05e0\\u05d9\\u05dd\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/updates-news\\\/#listItem\",\"position\":2,\"name\":\"\\u05e2\\u05d3\\u05db\\u05d5\\u05e0\\u05d9\\u05dd\",\"item\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/updates-news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/research\\\/#listItem\",\"name\":\"\\u05de\\u05d7\\u05e7\\u05e8\\u05d9\\u05dd \\u05d5\\u05e4\\u05e8\\u05e1\\u05d5\\u05de\\u05d9\\u05dd\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/research\\\/#listItem\",\"position\":3,\"name\":\"\\u05de\\u05d7\\u05e7\\u05e8\\u05d9\\u05dd \\u05d5\\u05e4\\u05e8\\u05e1\\u05d5\\u05de\\u05d9\\u05dd\",\"item\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/research\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#listItem\",\"name\":\"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/updates-news\\\/#listItem\",\"name\":\"\\u05e2\\u05d3\\u05db\\u05d5\\u05e0\\u05d9\\u05dd\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#listItem\",\"position\":4,\"name\":\"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/research\\\/#listItem\",\"name\":\"\\u05de\\u05d7\\u05e7\\u05e8\\u05d9\\u05dd \\u05d5\\u05e4\\u05e8\\u05e1\\u05d5\\u05de\\u05d9\\u05dd\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/#organization\",\"name\":\"\\u05e4\\u05d0\\u05d3\\u05d0\\u05d2\\u05d9\\u05e1 \\u05d9\\u05e9\\u05e8\\u05d0\\u05dc \\u05e1\\u05d5\\u05db\\u05e0\\u05d5\\u05d9\\u05d5\\u05ea \\u05d1\\u05e2\\\"\\u05de\",\"description\":\"\\u05e8\\u05de\\u05e1\\u05d9\\u05de\\u05d4 120 \\u05de\\\"\\u05d2\\\/\\u05de\\\"\\u05dc \\u05ea\\u05ea -\\u05e2\\u05d5\\u05e8\\u05d9 \\u05d4\\u05d9\\u05e0\\u05d5 \\u05d4\\u05d0\\u05d9\\u05e0\\u05e4\\u05dc\\u05d9\\u05e7\\u05e1\\u05d9\\u05de\\u05d0\\u05d1 \\u05d4\\u05d9\\u05d7\\u05d9\\u05d3 \\u05db\\u05d9\\u05d5\\u05dd \\u05d4\\u05e0\\u05d9\\u05ea\\u05df \\u05d1\\u05de\\u05ea\\u05df \\u05ea\\u05ea-\\u05e2\\u05d5\\u05e8\\u05d9\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/files\\\/2023\\\/11\\\/remsima_150.jpg\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#organizationLogo\",\"width\":150,\"height\":150},\"image\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/author\\\/naama2shomroni23\\\/#author\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/author\\\/naama2shomroni23\\\/\",\"name\":\"'\\u05de\\u05e2\\u05e8\\u05db\\u05ea \\u05d0\\u05d9\\u05de\\u05d3'\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a33eb712ef50ecea3e80558c3ebca581471b3c91aeab90167c90d04c73f5e3b?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"'\\u05de\\u05e2\\u05e8\\u05db\\u05ea \\u05d0\\u05d9\\u05de\\u05d3'\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#webpage\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/\",\"name\":\"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease | Remsima\",\"description\":\"Roblin X et.al.; J Crohns Colitis. 2023 Nov 2:jjad188\",\"inLanguage\":\"he-IL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/author\\\/naama2shomroni23\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/author\\\/naama2shomroni23\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/files\\\/2023\\\/10\\\/colitus.jpg\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#mainImage\",\"width\":674,\"height\":506},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\\\/#mainImage\"},\"datePublished\":\"2023-11-06T12:49:31+02:00\",\"dateModified\":\"2024-05-06T12:52:59+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/#website\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/\",\"name\":\"Remsima\",\"description\":\"\\u05e8\\u05de\\u05e1\\u05d9\\u05de\\u05d4 120 \\u05de\\\"\\u05d2\\\/\\u05de\\\"\\u05dc \\u05ea\\u05ea -\\u05e2\\u05d5\\u05e8\\u05d9 \\u05d4\\u05d9\\u05e0\\u05d5 \\u05d4\\u05d0\\u05d9\\u05e0\\u05e4\\u05dc\\u05d9\\u05e7\\u05e1\\u05d9\\u05de\\u05d0\\u05d1 \\u05d4\\u05d9\\u05d7\\u05d9\\u05d3 \\u05db\\u05d9\\u05d5\\u05dd \\u05d4\\u05e0\\u05d9\\u05ea\\u05df \\u05d1\\u05de\\u05ea\\u05df \\u05ea\\u05ea-\\u05e2\\u05d5\\u05e8\\u05d9\",\"inLanguage\":\"he-IL\",\"publisher\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease | Remsima","description":"Roblin X et.al.; J Crohns Colitis. 2023 Nov 2:jjad188","canonical_url":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/","robots":"max-image-preview:large","keywords":"article,\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd,\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#article","name":"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease | Remsima","headline":"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease","author":{"@id":"https:\/\/info.e-med.co.il\/remsima\/author\/naama2shomroni23\/#author"},"publisher":{"@id":"https:\/\/info.e-med.co.il\/remsima\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/info.e-med.co.il\/remsima\/files\/2023\/10\/colitus.jpg","width":674,"height":506},"datePublished":"2023-11-06T12:49:31+02:00","dateModified":"2024-05-06T12:52:59+03:00","inLanguage":"he-IL","mainEntityOfPage":{"@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#webpage"},"isPartOf":{"@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#webpage"},"articleSection":"Article, \u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd, \u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd"},{"@type":"BreadcrumbList","@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima#listItem","position":1,"name":"Home","item":"https:\/\/info.e-med.co.il\/remsima","nextItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/updates-news\/#listItem","name":"\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd"}},{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/updates-news\/#listItem","position":2,"name":"\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd","item":"https:\/\/info.e-med.co.il\/remsima\/updates-news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/research\/#listItem","name":"\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd"},"previousItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/research\/#listItem","position":3,"name":"\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd","item":"https:\/\/info.e-med.co.il\/remsima\/research\/","nextItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#listItem","name":"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease"},"previousItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/updates-news\/#listItem","name":"\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd"}},{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#listItem","position":4,"name":"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease","previousItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/research\/#listItem","name":"\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd"}}]},{"@type":"Organization","@id":"https:\/\/info.e-med.co.il\/remsima\/#organization","name":"\u05e4\u05d0\u05d3\u05d0\u05d2\u05d9\u05e1 \u05d9\u05e9\u05e8\u05d0\u05dc \u05e1\u05d5\u05db\u05e0\u05d5\u05d9\u05d5\u05ea \u05d1\u05e2\"\u05de","description":"\u05e8\u05de\u05e1\u05d9\u05de\u05d4 120 \u05de\"\u05d2\/\u05de\"\u05dc \u05ea\u05ea -\u05e2\u05d5\u05e8\u05d9 \u05d4\u05d9\u05e0\u05d5 \u05d4\u05d0\u05d9\u05e0\u05e4\u05dc\u05d9\u05e7\u05e1\u05d9\u05de\u05d0\u05d1 \u05d4\u05d9\u05d7\u05d9\u05d3 \u05db\u05d9\u05d5\u05dd \u05d4\u05e0\u05d9\u05ea\u05df \u05d1\u05de\u05ea\u05df \u05ea\u05ea-\u05e2\u05d5\u05e8\u05d9","url":"https:\/\/info.e-med.co.il\/remsima\/","logo":{"@type":"ImageObject","url":"https:\/\/info.e-med.co.il\/remsima\/files\/2023\/11\/remsima_150.jpg","@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#organizationLogo","width":150,"height":150},"image":{"@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/info.e-med.co.il\/remsima\/author\/naama2shomroni23\/#author","url":"https:\/\/info.e-med.co.il\/remsima\/author\/naama2shomroni23\/","name":"'\u05de\u05e2\u05e8\u05db\u05ea \u05d0\u05d9\u05de\u05d3'","image":{"@type":"ImageObject","@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4a33eb712ef50ecea3e80558c3ebca581471b3c91aeab90167c90d04c73f5e3b?s=96&d=mm&r=g","width":96,"height":96,"caption":"'\u05de\u05e2\u05e8\u05db\u05ea \u05d0\u05d9\u05de\u05d3'"}},{"@type":"WebPage","@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#webpage","url":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/","name":"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease | Remsima","description":"Roblin X et.al.; J Crohns Colitis. 2023 Nov 2:jjad188","inLanguage":"he-IL","isPartOf":{"@id":"https:\/\/info.e-med.co.il\/remsima\/#website"},"breadcrumb":{"@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#breadcrumblist"},"author":{"@id":"https:\/\/info.e-med.co.il\/remsima\/author\/naama2shomroni23\/#author"},"creator":{"@id":"https:\/\/info.e-med.co.il\/remsima\/author\/naama2shomroni23\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/info.e-med.co.il\/remsima\/files\/2023\/10\/colitus.jpg","@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#mainImage","width":674,"height":506},"primaryImageOfPage":{"@id":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/#mainImage"},"datePublished":"2023-11-06T12:49:31+02:00","dateModified":"2024-05-06T12:52:59+03:00"},{"@type":"WebSite","@id":"https:\/\/info.e-med.co.il\/remsima\/#website","url":"https:\/\/info.e-med.co.il\/remsima\/","name":"Remsima","description":"\u05e8\u05de\u05e1\u05d9\u05de\u05d4 120 \u05de\"\u05d2\/\u05de\"\u05dc \u05ea\u05ea -\u05e2\u05d5\u05e8\u05d9 \u05d4\u05d9\u05e0\u05d5 \u05d4\u05d0\u05d9\u05e0\u05e4\u05dc\u05d9\u05e7\u05e1\u05d9\u05de\u05d0\u05d1 \u05d4\u05d9\u05d7\u05d9\u05d3 \u05db\u05d9\u05d5\u05dd \u05d4\u05e0\u05d9\u05ea\u05df \u05d1\u05de\u05ea\u05df \u05ea\u05ea-\u05e2\u05d5\u05e8\u05d9","inLanguage":"he-IL","publisher":{"@id":"https:\/\/info.e-med.co.il\/remsima\/#organization"}}]},"og:locale":"he_IL","og:site_name":"Remsima | \u05e8\u05de\u05e1\u05d9\u05de\u05d4 120 \u05de&quot;\u05d2\/\u05de&quot;\u05dc \u05ea\u05ea -\u05e2\u05d5\u05e8\u05d9 \u05d4\u05d9\u05e0\u05d5 \u05d4\u05d0\u05d9\u05e0\u05e4\u05dc\u05d9\u05e7\u05e1\u05d9\u05de\u05d0\u05d1 \u05d4\u05d9\u05d7\u05d9\u05d3 \u05db\u05d9\u05d5\u05dd \u05d4\u05e0\u05d9\u05ea\u05df \u05d1\u05de\u05ea\u05df \u05ea\u05ea-\u05e2\u05d5\u05e8\u05d9","og:type":"article","og:title":"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease | Remsima","og:description":"Roblin X et.al.; J Crohns Colitis. 2023 Nov 2:jjad188","og:url":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/","article:published_time":"2023-11-06T10:49:31+00:00","article:modified_time":"2024-05-06T09:52:59+00:00","twitter:card":"summary","twitter:title":"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease | Remsima","twitter:description":"Roblin X et.al.; J Crohns Colitis. 2023 Nov 2:jjad188"},"aioseo_meta_data":{"post_id":"3700","title":null,"description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_custom_image_width":null,"og_custom_image_height":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"none","tabs":null,"priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"created":"2024-05-06 09:49:23","updated":"2026-05-15 00:39:37","primary_term":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"twitter_image_url":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"Article","isEnabled":true},"graphs":[]},"limit_modified_date":false,"ai":null,"seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/info.e-med.co.il\/remsima\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/info.e-med.co.il\/remsima\/updates-news\/\" title=\"\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd\">\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/info.e-med.co.il\/remsima\/research\/\" title=\"\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd\">\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tHigher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/info.e-med.co.il\/remsima"},{"label":"\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd","link":"https:\/\/info.e-med.co.il\/remsima\/updates-news\/"},{"label":"\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd","link":"https:\/\/info.e-med.co.il\/remsima\/research\/"},{"label":"Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease","link":"https:\/\/info.e-med.co.il\/remsima\/higher-serum-infliximab-concentrations-following-subcutaneous-dosing-are-associated-with-deep-remission-in-patients-with-inflammatory-bowel-disease\/"}],"_links":{"self":[{"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/posts\/3700","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/comments?post=3700"}],"version-history":[{"count":1,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/posts\/3700\/revisions"}],"predecessor-version":[{"id":3701,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/posts\/3700\/revisions\/3701"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/media\/3555"}],"wp:attachment":[{"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/media?parent=3700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/categories?post=3700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/tags?post=3700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}